RECRUITING

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Description

This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.

Study Overview

Study Details

Study overview

This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.

Brachytherapy Fractionation Individualized by Treatment Feasibility in Cervical Cancer: Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Condition
Cervical Cancers
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Histologically documented malignancy of the cervix and planned to receive brachytherapy as part of definitive treatment.
  • * ECOG performance status of 0-2
  • * Age ≥ 18 years old.
  • * Ability to understand and the willingness to provide written informed consent.
  • * Contraindication to receiving radiotherapy as determined by treating radiation oncologist.
  • * Contraindication to receiving MRI.
  • * Prior radiation to the pelvis \> 3 months ago
  • * Age \< 18 years old.
  • * Pregnant or breast-feeding

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Elizabeth Kidd, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2028-06